nuvoteQ.io
Adriaan Kruger is a seasoned entrepreneur and technology leader with extensive experience in software development and business management. As the Co-Founder and CEO of nuvoteQ.io since January 2014, Adriaan has driven the development of a diverse range of software products recognized by leading organizations globally. Adriaan also serves as Co-Founder of nuvoteQ Foundation and Scigenix, and as the Founder of Hazelwood Incub8or. In leadership roles such as Technology Team Lead for the Clinical Trial Community (Africa) and Advisory Board Member for SACRA South Africa, Adriaan is committed to advancing technology and innovation within the industry. Previous positions include Senior Partner at Cytespace Research and Divisional Head of Oracle Technology & Hardware at iOCO, along with roles at EOH and REO Consulting. Adriaan holds a B.IT (Hons) from the University of Pretoria and an MBA from Unisa Graduate School of Business Leadership.
This person is not in any teams
nuvoteQ.io
BUILT LOCALLY... TRUSTED GLOBALLY... In the fast-paced world of clinical research, getting medicines to market quickly and effectively is paramount. Clinical research organisations (CROs) face the challenge of conducting clinical trials in an affordable and efficient manner. However, existing methods and tools often fall short, being inflexible, slow, expensive, and lacking accuracy. Furthermore, there is a significant gap in credible and capable local solutions to support clinical trials. CROs who fail to perform effective clinical trials run the risk of not launching their products on time, losing significant market share and in some cases, even forfeiting the patent of their products. nuvoteQ is a trusted provider of digital technology solutions in the clinical and pharmaceutical research space. Based in Africa, we have developed a range of software products that are trusted by leading organisations worldwide. Our mission is to deliver cost-effective, flexible, and accessible software solutions with precise and high-quality results. nuvoteQ offers a range of powerful software products designed to empower clinical and pharmaceutical research organisations. With a proven track record and successful collaborations with industry giants, nuvoteQ has gained the trust of our clients. They rely on us to deliver exceptional service and results, allowing us to foster long-term partnerships. Additionally, we have established public partnerships, including our affiliation with the Gates Foundation. Our global footprint spans five continents and over 40 countries, reflecting the breadth of our reach. It's worth noting that all our work and platforms are FDA-approved, ensuring regulatory compliance and quality assurance.